Previous reports have also mentioned the abnormal expression of PSME3 in various types of cancer, including thyroid cancer, head and neck cancer, and osteosarcoma, which is consistent with our research findings (24–29). This evidence concerns the gene PSME3 and thyroid gland carcinoma.